Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
Clinical trial NCT00753545 · COMPLETED
Trial details
- NCT number
- NCT00753545
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-28
- Primary completion
- 2010-06-30
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.